Search - tctmd.com

Displaying 161 - 180 of 188

Sort: Relevancy | Date

News Daily News

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

Todd Neale

October 03, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

Presentation TCT 2013

Treatment of Complex Multivessel PCI. A New Sirolimus Chromium Cobalt Alloy DES. Study Design and Case Presentation

Presenter: Carlos Fernandez-Pereira

October 30, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

L.A. McKeown

October 09, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

Advertisement

DES Linked With Lower In-Hospital Mortality Than BMS for All PCI Indications

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

DES Outcomes Vary by Diabetes Status, Lesion Complexity

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Treatment of Complex Multivessel PCI. A New Sirolimus Chromium Cobalt Alloy DES. Study Design and Case Presentation

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

EES Outperform First-Generation DES in Treatment of CTOs

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content